skip to main content
Language:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Simple Search

Results 1 - 20 of 120  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients
Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients
Material Type:
Article 		Add to My Research

Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients

Investigational new drugs, 2017-08, Vol.35 (4), p.436-441 [Peer Reviewed Journal]

Springer Science+Business Media New York 2017 ;Investigational New Drugs is a copyright of Springer, 2017. ;ISSN: 0167-6997 ;EISSN: 1573-0646 ;DOI: 10.1007/s10637-017-0464-x ;PMID: 28396974

Full text available

Citations Cited by
2
Clinical Pharmacokinetics and Pharmacodynamics of Dabrafenib
Clinical Pharmacokinetics and Pharmacodynamics of Dabrafenib
Material Type:
Article 		Add to My Research

Clinical Pharmacokinetics and Pharmacodynamics of Dabrafenib

Clinical pharmacokinetics, 2019-04, Vol.58 (4), p.451-467 [Peer Reviewed Journal]

Springer Nature Switzerland AG 2018 ;Copyright Springer Nature B.V. Apr 2019 ;ISSN: 0312-5963 ;EISSN: 1179-1926 ;DOI: 10.1007/s40262-018-0703-0 ;PMID: 30094711

Full text available

Citations Cited by
3
Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma
Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma
Material Type:
Article 		Add to My Research

Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma

PloS one, 2012-05, Vol.7 (5), p.e37563 [Peer Reviewed Journal]

COPYRIGHT 2012 Public Library of Science ;COPYRIGHT 2012 Public Library of Science ;2012 Mir et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Mir et al. 2012 ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0037563 ;PMID: 22666367

Full text available

Citations Cited by
4
Differences in the spectrum of steroidogenic enzyme inhibition between Osilodrostat and Metyrapone in ACTH-dependent Cushing syndrome patients
Differences in the spectrum of steroidogenic enzyme inhibition between Osilodrostat and Metyrapone in ACTH-dependent Cushing syndrome patients
Material Type:
Article 		Add to My Research

Differences in the spectrum of steroidogenic enzyme inhibition between Osilodrostat and Metyrapone in ACTH-dependent Cushing syndrome patients

European journal of endocrinology, 2022-08, Vol.187 (2), p.315-322 [Peer Reviewed Journal]

European Society of Endocrinology ;Copyright BioScientifica Ltd. Aug 2022 ;ISSN: 0804-4643 ;EISSN: 1479-683X ;DOI: 10.1530/EJE-22-0208 ;PMID: 35699971

Full text available

Citations Cited by
5
Pharmacogenetic-Whole blood and intracellular pharmacokinetic-Pharmacodynamic (PG-PK2-PD) relationship of tacrolimus in liver transplant recipients
Pharmacogenetic-Whole blood and intracellular pharmacokinetic-Pharmacodynamic (PG-PK2-PD) relationship of tacrolimus in liver transplant recipients
Material Type:
Article 		Add to My Research

Pharmacogenetic-Whole blood and intracellular pharmacokinetic-Pharmacodynamic (PG-PK2-PD) relationship of tacrolimus in liver transplant recipients

PloS one, 2020-03, Vol.15 (3), p.e0230195 [Peer Reviewed Journal]

COPYRIGHT 2020 Public Library of Science ;COPYRIGHT 2020 Public Library of Science ;2020 Tron et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;2020 Tron et al 2020 Tron et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0230195 ;PMID: 32163483

Full text available

Citations Cited by
6
Drug-Induced Effects on Erlotinib Metabolism
Drug-Induced Effects on Erlotinib Metabolism
Material Type:
Article 		Add to My Research

Drug-Induced Effects on Erlotinib Metabolism

The New England journal of medicine, 2011-07, Vol.365 (4), p.379-380 [Peer Reviewed Journal]

Copyright © 2011 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc1105083 ;PMID: 21793762

Full text available

Citations Cited by
7
Development, Validation, and Comparison of Two Mass Spectrometry Methods (LC-MS/HRMS and LC-MS/MS) for the Quantification of Rituximab in Human Plasma
Development, Validation, and Comparison of Two Mass Spectrometry Methods (LC-MS/HRMS and LC-MS/MS) for the Quantification of Rituximab in Human Plasma
Material Type:
Article 		Add to My Research

Development, Validation, and Comparison of Two Mass Spectrometry Methods (LC-MS/HRMS and LC-MS/MS) for the Quantification of Rituximab in Human Plasma

Molecules (Basel, Switzerland), 2021-03, Vol.26 (5), p.1383 [Peer Reviewed Journal]

2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 1420-3049 ;EISSN: 1420-3049 ;DOI: 10.3390/molecules26051383 ;PMID: 33806585

Full text available

Citations Cited by
8
Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study
Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study
Material Type:
Article 		Add to My Research

Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study

Cancers, 2020-02, Vol.12 (2), p.473 [Peer Reviewed Journal]

2020 by the authors. 2020 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers12020473 ;PMID: 32085544

Full text available

Citations Cited by
9
The potential of microbiota information to better predict efficiency traits in growing pigs fed a conventional and a high-fiber diet
The potential of microbiota information to better predict efficiency traits in growing pigs fed a conventional and a high-fiber diet
Material Type:
Article 		Add to My Research

The potential of microbiota information to better predict efficiency traits in growing pigs fed a conventional and a high-fiber diet

Genetics selection evolution (Paris), 2024-01, Vol.56 (1), p.8-8, Article 8 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;ISSN: 1297-9686 ;ISSN: 0999-193X ;EISSN: 1297-9686 ;DOI: 10.1186/s12711-023-00865-4 ;PMID: 38243193

Full text available

Citations Cited by
10
Variability of Sorafenib Toxicity and Exposure over Time: A Pharmacokinetic/Pharmacodynamic Analysis
Variability of Sorafenib Toxicity and Exposure over Time: A Pharmacokinetic/Pharmacodynamic Analysis
Material Type:
Article 		Add to My Research

Variability of Sorafenib Toxicity and Exposure over Time: A Pharmacokinetic/Pharmacodynamic Analysis

The oncologist (Dayton, Ohio), 2012-09, Vol.17 (9), p.1204-1212 [Peer Reviewed Journal]

2012 AlphaMed Press ;AlphaMed Press 2012 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2011-0439 ;PMID: 22752067

Full text available

Citations Cited by
11
Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cancer
Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cancer
Material Type:
Article 		Add to My Research

Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cancer

Cancers, 2023-01, Vol.15 (1), p.313 [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15010313 ;PMID: 36612311

Full text available

Citations Cited by
12
Early sorafenib-induced toxicity is associated with drug exposure and UGTIA9 genetic polymorphism in patients with solid tumors: a preliminary study
Early sorafenib-induced toxicity is associated with drug exposure and UGTIA9 genetic polymorphism in patients with solid tumors: a preliminary study
Material Type:
Article 		Add to My Research

Early sorafenib-induced toxicity is associated with drug exposure and UGTIA9 genetic polymorphism in patients with solid tumors: a preliminary study

PloS one, 2012-08, Vol.7 (8), p.e42875 [Peer Reviewed Journal]

COPYRIGHT 2012 Public Library of Science ;COPYRIGHT 2012 Public Library of Science ;Boudou-Rouquette et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2012 Boudou-Rouquette et al 2012 Boudou-Rouquette et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0042875 ;PMID: 22912756

Full text available

Citations Cited by
13
Gut microbiota and host genetics contribute to the phenotypic variation of digestive and feed efficiency traits in growing pigs fed a conventional and a high fiber diet
Gut microbiota and host genetics contribute to the phenotypic variation of digestive and feed efficiency traits in growing pigs fed a conventional and a high fiber diet
Material Type:
Article 		Add to My Research

Gut microbiota and host genetics contribute to the phenotypic variation of digestive and feed efficiency traits in growing pigs fed a conventional and a high fiber diet

Genetics selection evolution (Paris), 2022-07, Vol.54 (1), p.55-55, Article 55 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. ;Attribution ;The Author(s) 2022 ;ISSN: 1297-9686 ;ISSN: 0999-193X ;EISSN: 1297-9686 ;DOI: 10.1186/s12711-022-00742-6 ;PMID: 35896976

Full text available

Citations Cited by
14
Hydroxychloroquine sulfate: A novel treatment for lipin-1 deficiency?
Hydroxychloroquine sulfate: A novel treatment for lipin-1 deficiency?
Material Type:
Article 		Add to My Research

Hydroxychloroquine sulfate: A novel treatment for lipin-1 deficiency?

Biomedicine & pharmacotherapy, 2023-07, Vol.163, p.114813-114813, Article 114813 [Peer Reviewed Journal]

2023 The Authors ;Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved. ;ISSN: 0753-3322 ;EISSN: 1950-6007 ;DOI: 10.1016/j.biopha.2023.114813 ;PMID: 37150031

Full text available

Citations Cited by
15
Low-dose mycophenolate mofetil improves survival in a murine model of Staphylococcus aureus sepsis by increasing bacterial clearance and phagocyte function
Low-dose mycophenolate mofetil improves survival in a murine model of Staphylococcus aureus sepsis by increasing bacterial clearance and phagocyte function
Material Type:
Article 		Add to My Research

Low-dose mycophenolate mofetil improves survival in a murine model of Staphylococcus aureus sepsis by increasing bacterial clearance and phagocyte function

Frontiers in immunology, 2022-07, Vol.13, p.939213-939213 [Peer Reviewed Journal]

Copyright © 2022 Alby-Laurent, Belaïdouni, Blanchet, Rousseau, Llitjos, Sanquer, Mira, Pène, Toubiana and Chiche 2022 Alby-Laurent, Belaïdouni, Blanchet, Rousseau, Llitjos, Sanquer, Mira, Pène, Toubiana and Chiche ;ISSN: 1664-3224 ;EISSN: 1664-3224 ;DOI: 10.3389/fimmu.2022.939213 ;PMID: 35936013

Full text available

Citations Cited by
16
Cross-Validation of a Multiplex LC-MS/MS Method for Assaying mAbs Plasma Levels in Patients with Cancer: A GPCO-UNICANCER Study
Cross-Validation of a Multiplex LC-MS/MS Method for Assaying mAbs Plasma Levels in Patients with Cancer: A GPCO-UNICANCER Study
Material Type:
Article 		Add to My Research

Cross-Validation of a Multiplex LC-MS/MS Method for Assaying mAbs Plasma Levels in Patients with Cancer: A GPCO-UNICANCER Study

Pharmaceuticals (Basel, Switzerland), 2021-08, Vol.14 (8), p.796 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 1424-8247 ;EISSN: 1424-8247 ;DOI: 10.3390/ph14080796 ;PMID: 34451893

Full text available

Citations Cited by
17
Association between Olaparib Exposure and Early Toxicity in BRCA-Mutated Ovarian Cancer Patients: Results from a Retrospective Multicenter Study
Association between Olaparib Exposure and Early Toxicity in BRCA-Mutated Ovarian Cancer Patients: Results from a Retrospective Multicenter Study
Material Type:
Article 		Add to My Research

Association between Olaparib Exposure and Early Toxicity in BRCA-Mutated Ovarian Cancer Patients: Results from a Retrospective Multicenter Study

Pharmaceuticals (Basel, Switzerland), 2021-08, Vol.14 (8), p.804 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 1424-8247 ;EISSN: 1424-8247 ;DOI: 10.3390/ph14080804 ;PMID: 34451901

Full text available

Citations Cited by
18
Effects of acyl-coenzyme A binding protein (ACBP)/diazepam-binding inhibitor (DBI) on body mass index
Effects of acyl-coenzyme A binding protein (ACBP)/diazepam-binding inhibitor (DBI) on body mass index
Material Type:
Article 		Add to My Research

Effects of acyl-coenzyme A binding protein (ACBP)/diazepam-binding inhibitor (DBI) on body mass index

Cell death & disease, 2021-06, Vol.12 (6), p.599-14, Article 599 [Peer Reviewed Journal]

The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;The Author(s) 2021 ;ISSN: 2041-4889 ;EISSN: 2041-4889 ;DOI: 10.1038/s41419-021-03864-9 ;PMID: 34108446

Full text available

Citations Cited by
19
Hydroxychloroquine Protects against Cardiac Ischaemia/Reperfusion Injury In Vivo via Enhancement of ERK1/2 Phosphorylation
Hydroxychloroquine Protects against Cardiac Ischaemia/Reperfusion Injury In Vivo via Enhancement of ERK1/2 Phosphorylation
Material Type:
Article 		Add to My Research

Hydroxychloroquine Protects against Cardiac Ischaemia/Reperfusion Injury In Vivo via Enhancement of ERK1/2 Phosphorylation

PloS one, 2015-12, Vol.10 (12), p.e0143771-e0143771 [Peer Reviewed Journal]

COPYRIGHT 2015 Public Library of Science ;COPYRIGHT 2015 Public Library of Science ;2015 Bourke et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Bourke et al 2015 Bourke et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0143771 ;PMID: 26636577

Full text available

Citations Cited by
20
Pharmacokinetics and pharmacodynamics of tacrolimus in liver transplant recipients: inside the white blood cells
Pharmacokinetics and pharmacodynamics of tacrolimus in liver transplant recipients: inside the white blood cells
Material Type:
Article 		Add to My Research

Pharmacokinetics and pharmacodynamics of tacrolimus in liver transplant recipients: inside the white blood cells

Clinical biochemistry, 2015-04, Vol.48 (6), p.406-411 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0009-9120 ;EISSN: 1873-2933 ;DOI: 10.1016/j.clinbiochem.2014.12.018 ;PMID: 25562187

Digital Resources/Online E-Resources

Citations Cited by

Results 1 - 20 of 120  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (102)

Refine My Results

Creation Date 

From To
Refine
  1. Before 2009  (4)
  2. 2009 To 2011  (12)
  3. 2012 To 2014  (20)
  4. 2015 To 2018  (29)
  5. After 2018  (55)
  6. More options open sub menu

Resource Type 

  1. Articles  (105)
  2. Conference Proceedings  (6)
  3. Images  (3)
  4. Reports  (3)
  5. Patents  (3)
  6. More options open sub menu

Language 

  1. English  (113)
  2. Japanese  (15)
  3. French  (10)
  4. German  (4)
  5. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait